Catalyst Wire Dossier Catalyst Wire Dossier

Dengue 1,2,3,4 (Attenuated) Vaccine

· Butantan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dengue 1,2,3,4 (Attenuated) Vaccine, covering 2019-01-16 to 2019-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine [Phase 2]

See pricing